Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Irvine

Showing results (411-420 of 487) with videos related to

Pageof 49
Sort By:
Journal of the American Academy of Dermatology|July 7, 2026
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension studyAlan D Irvine, Amy S Paller, Elaine C Siegfried, et al.
The Journal of Allergy and Clinical Immunology|February 11, 2012
Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiencySanja Kezic, Gráinne M O'Regan, René Lutter, et al.
European Journal of Medical Genetics|October 12, 2022
The VASCERN-VASCA working group diagnostic and management pathways for lymphatic malformationsNader Ghaffarpour, Eulalia Baselga, Laurence M Boon, et al.
The British Journal of Dermatology|January 23, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)Jonathan I Silverberg, Lawrence F Eichenfield, Andrew Blauvelt, et al.
Journal of Vascular Anomalies|June 19, 2023
The VASCERN-VASCA Working Group Diagnostic and Management Pathways for Venous MalformationsAnne Dompmartin, Eulalia Baselga, Laurence M Boon, et al.
The British Journal of Dermatology|February 6, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registriesF M Vermeulen, L A A Gerbens, A L Bosma, et al.
Nature Genetics|April 8, 2009
A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen primingPadraic G Fallon, Takashi Sasaki, Aileen Sandilands, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2023
Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitisYael Renert-Yuval, Ester Del Duca, Bernd Arents, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2015
Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetesJochen Schmitt, Kristin Schwarz, Hansjörg Baurecht, et al.
Human Mutation|December 17, 2013
Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti diseaseMatilde Immacolata Conte, Alessandra Pescatore, Mariateresa Paciolla, et al.
Pageof 49

Showing results (411-420 of 487) with videos related to

Sort By:
Pageof 49
Journal of the American Academy of Dermatology|July 7, 2026
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension studyAlan D Irvine, Amy S Paller, Elaine C Siegfried, et al.
The Journal of Allergy and Clinical Immunology|February 11, 2012
Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiencySanja Kezic, Gráinne M O'Regan, René Lutter, et al.
European Journal of Medical Genetics|October 12, 2022
The VASCERN-VASCA working group diagnostic and management pathways for lymphatic malformationsNader Ghaffarpour, Eulalia Baselga, Laurence M Boon, et al.
The British Journal of Dermatology|January 23, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)Jonathan I Silverberg, Lawrence F Eichenfield, Andrew Blauvelt, et al.
Journal of Vascular Anomalies|June 19, 2023
The VASCERN-VASCA Working Group Diagnostic and Management Pathways for Venous MalformationsAnne Dompmartin, Eulalia Baselga, Laurence M Boon, et al.
The British Journal of Dermatology|February 6, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registriesF M Vermeulen, L A A Gerbens, A L Bosma, et al.
Nature Genetics|April 8, 2009
A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen primingPadraic G Fallon, Takashi Sasaki, Aileen Sandilands, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2023
Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitisYael Renert-Yuval, Ester Del Duca, Bernd Arents, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2015
Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetesJochen Schmitt, Kristin Schwarz, Hansjörg Baurecht, et al.
Human Mutation|December 17, 2013
Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti diseaseMatilde Immacolata Conte, Alessandra Pescatore, Mariateresa Paciolla, et al.
Pageof 49